NDC11 66302065003
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 66302-0650-03 | 66302-0650 |
| 66302-0650-3 | 66302-0650 |
| 66302-650-03 | 66302-650 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tyvaso DPI | TREPROSTINIL | United Therapeutics Corporation | ddc3d400-bcb3-4b09-aae2-0768b10a5b0f | 2025-11-20 | Warnings, Adverse reactions | 66302-650-03 66302-650 66302065003 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.